Articles published by Genmab A/S
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Financial Results for the First Nine Months of 2023
November 07, 2023
From Genmab A/S
Via GlobeNewswire
![](https://mms.businesswire.com/media/20231102484885/en/1932449/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
From Genmab A/S
Via GlobeNewswire
![](https://mms.businesswire.com/media/20230918654455/en/1893347/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20230922309616/en/1897276/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20230904469378/en/1880973/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Financial Results for the First Half of 2023
August 03, 2023
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20230719052574/en/1845268/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://mms.businesswire.com/media/20230525005851/en/1803969/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20230518005495/en/1797676/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Initiation of Share Buy-Back Program
February 22, 2023
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
January 24, 2023
From Genmab A/S
Via GlobeNewswire
![](https://mms.businesswire.com/media/20221221005016/en/1669857/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20221211005057/en/1661419/5/Genmab_Logo_Color_RGB.jpg)
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Genmab Announces Financial Results for the First Nine Months of 2022
November 09, 2022
From Genmab A/S
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.